Statherin-derived peptides as antifungal strategy against Candida albicans.

The aim of this in vitro study was to evaluate the effect of statherin and its naturally occurring peptides (DR9-2, DR9, GE-12, IT-32, GQ-19, IP-18) on Candida albicans metabolism and biofilm development. After the killing assay, a peptide pellicle was formed on the bottom of a polystyrene plate at the IC50 of each peptide. Over the peptide pellicle, Candida albicans biofilm (48 h) was grown. The peptides antimicrobial activity after the peptides treatment was evaluated by alamarBlue, total biofilm biomass and colony forming units (CFU) counting. The pellicle with statherin and the peptides (DR9-2, DR9, GE-12, IP-18, GQ-19) was able to reduce he viability of Candida albicans compared to the negative control. They also decreased cell proliferation by 20 % and total biomass. IT-32 showed the highest reduction in cell proliferation and biomass, which was similar to the positive control, histatin 5. These results suggest that the naturally occuring peptides from statherin are able to decrease Candida albicans colonization and biofilm proliferation. Copyright © 2021 Elsevier Ltd. All rights reserved.

Citation

Claudia Viviane Guimarães Pellissari, Janaina Habib Jorge, Lina Maria Marin, Robinson Sabino-Silva, Walter Luiz Siqueira. Statherin-derived peptides as antifungal strategy against Candida albicans. Archives of oral biology. 2021 May;125:105106

Mesh Tags

Substances

PMID: 33740624

search → result